Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 2
1986 1
1988 1
1989 3
1990 1
1991 5
1992 4
1993 6
1994 9
1995 11
1996 13
1997 11
1998 10
1999 5
2000 10
2001 8
2002 7
2003 10
2004 7
2005 11
2006 24
2007 18
2008 18
2009 12
2010 21
2011 12
2012 14
2013 15
2014 14
2015 14
2016 16
2017 24
2018 19
2019 35
2020 29
2021 21
2022 8
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Results by year

Filters applied: . Clear all
Page 1
Dose adjustment in patients with liver disease.
Delcò F, Tchambaz L, Schlienger R, Drewe J, Krähenbühl S. Delcò F, et al. Among authors: krahenbuhl s. Drug Saf. 2005;28(6):529-45. doi: 10.2165/00002018-200528060-00005. Drug Saf. 2005. PMID: 15924505 Review.
Medikamentöse Hepatopathien.
Krähenbühl S, Pichler WJ. Krähenbühl S, et al. Ther Umsch. 2017 Jul;74(3):123-130. doi: 10.1024/0040-5930/a000895. Ther Umsch. 2017. PMID: 28777047 Review. German. No abstract available.
Mechanisms of statin-associated skeletal muscle-associated symptoms.
Bouitbir J, Sanvee GM, Panajatovic MV, Singh F, Krähenbühl S. Bouitbir J, et al. Among authors: krahenbuhl s. Pharmacol Res. 2020 Apr;154:104201. doi: 10.1016/j.phrs.2019.03.010. Epub 2019 Mar 12. Pharmacol Res. 2020. PMID: 30877064 Review.
Lifestyle-Medikamente: Vergnügen ohne Ende?
Krähenbühl S. Krähenbühl S. Ther Umsch. 2016 Nov;73(11):701-706. doi: 10.1024/0040-5930/a000853. Ther Umsch. 2016. PMID: 28276266 Review. German. No abstract available.
[Drug-induced sexual dysfunction].
Taegtmeyer AB, Krähenbühl S. Taegtmeyer AB, et al. Among authors: krahenbuhl s. Ther Umsch. 2015 Dec;72(11-12):711-5. doi: 10.1024/0040-5930/a000741. Ther Umsch. 2015. PMID: 26654815 German.
Targeting immunoliposomes to EGFR-positive glioblastoma.
Kasenda B, König D, Manni M, Ritschard R, Duthaler U, Bartoszek E, Bärenwaldt A, Deuster S, Hutter G, Cordier D, Mariani L, Hench J, Frank S, Krähenbühl S, Zippelius A, Rochlitz C, Mamot C, Wicki A, Läubli H. Kasenda B, et al. Among authors: krahenbuhl s. ESMO Open. 2022 Feb;7(1):100365. doi: 10.1016/j.esmoop.2021.100365. Epub 2022 Jan 5. ESMO Open. 2022. PMID: 34998092 Free PMC article. Clinical Trial.
Drug interaction potential of resveratrol.
Detampel P, Beck M, Krähenbühl S, Huwyler J. Detampel P, et al. Among authors: krahenbuhl s. Drug Metab Rev. 2012 Aug;44(3):253-65. doi: 10.3109/03602532.2012.700715. Drug Metab Rev. 2012. PMID: 22788578 Review.
Mitochondria: important target for drug toxicity?
Krähenbühl S. Krähenbühl S. J Hepatol. 2001 Feb;34(2):334-6. doi: 10.1016/s0168-8278(00)00106-9. J Hepatol. 2001. PMID: 11281565 Review. No abstract available.
[Gout management: an update].
Ankli B, Krähenbühl S. Ankli B, et al. Among authors: krahenbuhl s. Ther Umsch. 2016;73(3):115-24. doi: 10.1024/0040-5930/a000766. Ther Umsch. 2016. PMID: 27008442 Review. German.
411 results